BIO-key Q2 FY26 net loss narrows to $0.57 million; revenue rises 13% to $1.92 million vs Q2 FY25

Reuters2026/08/13 20:54

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BIO-key reported Q2 revenue up 13% to $1.92 million, driven by license revenue up 53% to $1.23 million.
Net loss narrowed to $575,000 from a year earlier, while operating loss improved to $533,000.
Gross profit margin widened to 87% from 73% on lower total cost of goods sold, which fell 47% to $245,951.
Service revenue fell 28% to $231,005 on lower maintenance and support renewals, while hardware revenue dropped 19% to $459,641.
Cash and cash equivalents totaled $1.38 million at June 30, 2026; net cash used in operations was $1.2 million for six months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-027723), on August 13, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BIO-key Q2 FY26 net loss narrows to $0.57 million; revenue rises 13% to $1.92 million vs Q2 FY25

You may also like

Crypto prices